Histologically, BMP9 significantly alleviated hepatic steatosis and hepatocyte ballooning in HFD-fed mice (Figure 3C), and the NAS was clearly decreased in BMP9-treated mice compared to untreated mice. The gene discussed is GDF2; the disease is Hepatic steatosis.